Global Oligonucleotide Synthesis Market to Reach US$3.4 Billion by the Year 2027
Amid the COVID-19 crisis, the global market for Oligonucleotide Synthesis estimated at US$1.8 Billion in the year 2020, is projected to reach a revised size of US$3.4 Billion by 2027, growing at a CAGR of 9.5% over the analysis period 2020-2027.Synthesized Oligonucleotides, one of the segments analyzed in the report, is projected to grow at a 9.9% CAGR to reach US$1.7 Billion by the end of the analysis period.After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Reagents segment is readjusted to a revised 9.4% CAGR for the next 7-year period. This segment currently accounts for a 36.7% share of the global Oligonucleotide Synthesis market.
The U.S. Accounts for Over 27% of Global Market Size in 2020, While China is Forecast to Grow at a 12.6% CAGR for the Period of 2020-2027
The Oligonucleotide Synthesis market in the U.S. is estimated at US$481.6 Million in the year 2020. The country currently accounts for a 27.03% share in the global market. China, the world second largest economy, is forecast to reach an estimated market size of US$709.6 Million in the year 2027 trailing a CAGR of 12.6% through 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.5% and 8.1% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 7.4% CAGR while Rest of European market (as defined in the study) will reach US$709.6 Million by the year 2027.
Equipment Segment Corners a 14.8% Share in 2020
In the global Equipment segment, USA, Canada, Japan, China and Europe will drive the 7.7% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$198.6 Million in the year 2020 will reach a projected size of US$334.8 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$479.3 Million by the year 2027, while Latin America will expand at a 9.7% CAGR through the analysis period. We bring years of research experience to this 6th edition of our report. The 377-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.
- Competitors identified in this market include, among others,
- ATDBio Ltd.
- Bio-Synthesis Inc.
- GE Healthcare Life Sciences
- GeneDesign, Inc.
- GenScript Biotech Corporation
- Integrated DNA Technologies (IDT), Inc.
- LGC Biosearch Technologies
- Merck KgaA
- Nitto Denko Avecia Inc.
- Thermo Fisher Scientific, Inc.